NEURODISCOVERY LIMITED (NDL)

Neurology Research and Development

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
NDL	0.039	0%	0.039	0.045	0.000	0.000	0.000	0

NEURODISCOVERY LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	NDL
Securities	ASX Code, Security Description ------------------------------ NDL, Ordinary Fully Paid
Official Listing Date	15 August, 2005
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.neurodiscoveryltd.com
Registered Office Address	Unit 16, 589 Stirling Highway, Cottesloe, WA, AUSTRALIA, 6011
Head Office Telephone	(08) 9388 6069
Head Office Fax	(08) 6380 1026
Share Registry	SECURITY TRANSFER REGISTRARS PTY. LIMITED 770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone	(08) 9315 2333

Directors / Senior Management
Dr Roger Aston (Executive Chairman) Mr Martin Rogers (Deputy Chairman) Mr David McAuliffe (Non Exec. Director) Mr Simon O'Loughlin (Non Exec. Director)

Company Secretary	Mr Robert Hodby
Principal Activities	Neurology Research and Development

NEURODISCOVERY LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
22/05/2013		Results of Meeting	1	PDF
13/05/2013		Japanese patent granted	1	PDF
26/04/2013		Appendix 4C - quarterly	5	PDF
22/04/2013		Change of Director's Interest Notice	3	PDF
19/04/2013		Notice of Extraordinary General Meeting/Proxy Form	20	PDF
17/04/2013		Becoming a substantial holder x 3	6	PDF
16/04/2013		Completion of Acquisition & Appendix 3B	13	PDF
11/04/2013		Initial Director's Interest Notice	2	PDF
08/04/2013		Ceasing to be a substantial holder	1	PDF
04/04/2013		Change of Director's Interest Notice	3	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
23 May 2013	0.039	-4.88%	0.040	0.039	200,000
22 May 2013	0.041	2.5%	0.041	0.041	230,000
21 May 2013	0.040	5.26%	0.044	0.038	1,309,714
17 May 2013	0.038	-9.52%	0.043	0.038	355,000
16 May 2013	0.042	5%	0.045	0.042	655,697

* Volume of shares shown represents only those shares traded on ASX.

NEURODISCOVERY LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NDL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NDL

Warrants & Structured Products

No warrants & Structured Products are available over the security NDL

ASX CFDs

No Contracts For Differences are available over the security NDL

MyASX: Login | Sign up